Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc. scores highest on Torque (55) and lowest on Nitro (12). Its PosiPenta is 33.57 out of 100, weaker than most similar companies.
On the Penta Grid this week, Acurx Pharmaceuticals, Inc. is Grid #702 of 837 in the Healthcare sector in United States, and Grid #3,396 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Acurx Pharmaceuticals, Inc. | 33.57 | 43 | 36 | 12 | 55 | 22 |
| AIM ImmunoTech Inc. | 23.91 | 21 | 49 | 8 | 15 | 27 |
| Enveric Biosciences, Inc. | 38.46 | 43 | 40 | 16 | 53 | 40 |
| Tenon Medical, Inc. | 22.28 | 0 | 35 | 10 | 35 | 31 |
| Moleculin Biotech, Inc. | 43.19 | 95 | 48 | 9 | 34 | 30 |
| Senti Biosciences Holdings, Inc. | 19.99 | 0 | 44 | 10 | 6 | 40 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.41 |
| P/B ratio | 0.75 |
EEarnings
| Trailing EPS | ₹-252.89 |
| Forward EPS | ₹-165.75 |
NNitro
| Price | 104.19 |
| 52-week high | 714.06 |
| 52-week low | 101.23 |
| Fall from 52-week high | 85.4% |
TTorque
| Return on equity (ROE) | -128.11% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | -2.05 |
| Market cap | ₹57 Cr |
| Insider holding | 2.31% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Acurx Pharmaceuticals, Inc.'s PosiPenta score?
Acurx Pharmaceuticals, Inc.'s PosiPenta is 33.57 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Acurx Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, Acurx Pharmaceuticals, Inc. is Grid #702 of 837 in the Healthcare sector in United States, and Grid #3,396 of 4,000 in United States.
Which PosiPenta pillar is strongest for Acurx Pharmaceuticals, Inc.?
Torque (durability), with a score of 55 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Acurx Pharmaceuticals, Inc.?
Nitro (momentum), with a score of 12 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.